Ventricular fibrillation due to long QT syndrome probably caused by clindamycin

American Journal of Cardiology

Volumn 83, Issue 5, 1999, Pages 813-815

  Gabel, Andreas ^a   Schymik, Gerhard ^a   Mehmel, Helmuth Christian ^a  

^a STÄDTISCHES KLINIKUM KARLSRUHE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; AMIODARONE; AMITRIPTYLINE; ANTIARRHYTHMIC AGENT; ANTIHISTAMINIC AGENT; ASTEMIZOLE; CHLORPROMAZINE; CLINDAMYCIN; CLOMIPRAMINE; DISOPYRAMIDE; DOXEPIN; ERYTHROMYCIN; HALOPERIDOL; IMIPRAMINE; LIDOFLAZINE; MAPROTILINE; PENTAMIDINE; PHENOTHIAZINE DERIVATIVE; PRENYLAMINE; PROCAINAMIDE; QUINIDINE; SOTALOL; SPIRAMYCIN; SULFAMETHOXAZOLE; TERFENADINE; TETRACYCLIC ANTIDEPRESSANT AGENT; THIORIDAZINE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIMETHOPRIM; UNINDEXED DRUG;

AGED; ANTIBIOTIC THERAPY; ARTICLE; CASE REPORT; DRUG BLOOD LEVEL; DRUG CONTRAINDICATION; DRUG EFFECT; DRUG ELIMINATION; DRUG HALF LIFE; DRUG PROTEIN BINDING; FEMALE; GRAFT INFECTION; HEART VENTRICLE FIBRILLATION; HUMAN; INFECTION; KNEE PROSTHESIS; LONG QT SYNDROME; PATHOGENESIS; PRIORITY JOURNAL; QT INTERVAL; TORSADE DES POINTES;

AGED; ANTI-BACTERIAL AGENTS; ARTHROPLASTY, REPLACEMENT, KNEE; CLINDAMYCIN; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; KNEE PROSTHESIS; LONG QT SYNDROME; PROSTHESIS-RELATED INFECTIONS; RECURRENCE; REOPERATION; RESUSCITATION; RETREATMENT; VENTRICULAR FIBRILLATION;

EID: 0033104194     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(98)00995-3     Document Type: Article

References (11)

1. Haverkamp W., Hordt M., Borggrefe M., Breithardt G. Torsade de pointes and QT syndrome. Med Klin. 90:1995;240-245.
2. Braunwald E. Heart Disease: A Textbook of Cardiovascular Medicine. 5th ed. Philadelphia: WB Saunders, 1997.
3. Nattel S., Ranger S., Talajic M., Lemery R., Roy D. Erythromycin induced long QT syndrome concordance with quinidine and underlying cellular electrophysiologic mechanisms . Am J Med. 89:1990;235-238.
4. Morey T.E., Martynyuk A.E., Napolitano C.A. Ionic basis of differential effects of intravenous anesthetics on erythromycin-induced prolongation of ventricular repolarization in the guinea pig heart. Anesthesiology. 87:1997;1172-1181.
5. Vogt A.W., Zollo R.A. Long QT syndrome associated with oral erythromycin used in preoperative bowel preparation. Anesth Analg. 85:1997;1011-1013.
6. Lin J.C., Quasny H.A. QT prolongation and development of torsades de pointes with the concomitant administration of oral erythromycin base and quinidine. Pharmacotherapy. 17:1997;626-630.
7. Verdun F., Mansourati J., Jobic Y. Torsades de pointe with spiramycine and metiquazine therapy. Apropos of a case. Arch Mal Coeur Vaiss. 90:1997;103-106.
8. Stramba Badiale M., Nador F., Porta N. QT interval prolongation and risk of life-threatening arrhythmias during toxoplasmosis prophylaxis with spiramycin in neonates. Am Heart J. 133:1997;108-111.
9. Lopez J.A., Harold J.G., Rosenthal M.C., Oseran D.S., Schapira J.N., Peter T. QT prolongation and torsade de pointes after administration of trimethoprim-sulfamethoxazol. Am J Cardiol. 59:1987;376-377.
10. Stein K.M., Fenton C., Lehany A.M., Okin P.M., Kligfield P. Incidence of QT interval prolongation during pentamidine therapy of pneumocystis carinii pneumonia. Am J Cardiol. 68:1991;1091-1094.
11. Forth W., Henschler D., Rummel W. Allgemeine und spezielle Pharmakologie und Toxikologie. 7th ed. 1996;Spektrum Akademischer Verlag, Heidelberg.